{"nct_id":"NCT05382286","title":"Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast Cancer","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-09","start_date":"2022-07-25","start_date_type":"ACTUAL","primary_completion_date":"2027-02","primary_completion_date_type":"ESTIMATED","completion_date":"2027-02","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["GILD"]}